DE973095C
(de)
|
1955-01-19 |
1959-12-03 |
Kalle & Co Ag |
Verfahren zur UEberfuehrung von OElen in streufaehige Pulver durch Spruehtrocknung von OEl-in-Wasser-Emulsionen
|
HU176101B
(en)
|
1977-12-29 |
1980-12-28 |
Gyogyszerkutato Intezet |
Process for producing bis-bracket-nitrozo-ureido-bracket closed-polyol derivatives
|
DE3013839A1
(de)
|
1979-04-13 |
1980-10-30 |
Freunt Ind Co Ltd |
Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
FR2525108B1
(fr)
|
1982-04-19 |
1989-05-12 |
Elan Corp Ltd |
Medicaments a haut degre de solubilite et procede pour leur obtention
|
US4629621A
(en)
*
|
1984-07-23 |
1986-12-16 |
Zetachron, Inc. |
Erodible matrix for sustained release bioactive composition
|
JPS61205208A
(ja)
|
1985-03-08 |
1986-09-11 |
Yamanouchi Pharmaceut Co Ltd |
難溶性医薬品の速溶性製剤
|
US4590065A
(en)
|
1985-04-18 |
1986-05-20 |
Colgate-Palmolive Company |
Stable flavor-containing dentifrice
|
US4758427A
(en)
|
1985-08-08 |
1988-07-19 |
Ciba-Geigy Corporation |
Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
|
PH22025A
(en)
|
1985-08-19 |
1988-05-13 |
Johnson & Son Inc S C |
Aqueous pyrethroid insecticidal formulations and method of increasing the stability thereof
|
DE3612211A1
(de)
|
1986-04-11 |
1987-10-15 |
Basf Ag |
Kontinuierliches verfahren zum tablettieren
|
DE3612212A1
(de)
|
1986-04-11 |
1987-10-15 |
Basf Ag |
Verfahren zur herstellung von festen pharmazeutischen formen
|
ATE68704T1
(de)
*
|
1986-12-18 |
1991-11-15 |
Bauer Kurt Heinz |
Gegenueber lichteinfluss stabilisiertes nifedipin- konzentrat und verfahren zu seiner herstellung.
|
US4804699A
(en)
*
|
1987-05-15 |
1989-02-14 |
Ici Americas Inc. |
Monomeric and oligomeric glutarate-based light stabilizers for plastics
|
IL87710A
(en)
*
|
1987-09-18 |
1992-06-21 |
Ciba Geigy Ag |
Covered floating retard form for controlled release in gastric juice
|
AU2902289A
(en)
|
1987-12-08 |
1989-07-05 |
Mark Chasin |
Method of forming bioerodible implants for improved controlled drug release
|
DE3812567A1
(de)
|
1988-04-15 |
1989-10-26 |
Basf Ag |
Verfahren zur herstellung pharmazeutischer mischungen
|
DE3830353A1
(de)
|
1988-09-07 |
1990-03-15 |
Basf Ag |
Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
|
US5368864A
(en)
|
1988-11-25 |
1994-11-29 |
Henning Berlin Gmbh Chemie- Und Pharmawerk |
Formulation of oxypurinol and/or its alkali and alkaline earth salts
|
GB8903328D0
(en)
|
1989-02-14 |
1989-04-05 |
Ethical Pharma Ltd |
Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
|
US5539122A
(en)
|
1989-05-23 |
1996-07-23 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
US5354866A
(en)
|
1989-05-23 |
1994-10-11 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
HU204529B
(en)
|
1989-08-10 |
1992-01-28 |
Richter Gedeon Vegyeszet |
Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
|
US5075291A
(en)
|
1989-11-22 |
1991-12-24 |
Ici Americas Inc. |
Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound
|
CA2059555A1
(en)
|
1990-06-01 |
1991-12-02 |
Merrick L. Shively |
Self-emulsifying glasses
|
SE9003296L
(sv)
|
1990-10-16 |
1992-04-17 |
Kabi Pharmacia Ab |
Foerfarande foer att formulera laekemedel
|
DE69127457T2
(de)
*
|
1990-11-28 |
1998-01-22 |
Taisho Pharmaceutical Co., Ltd., Tokio/Tokyo |
6-0-methylerythromycin a-derivat
|
WO1992018106A1
(en)
|
1991-04-16 |
1992-10-29 |
Nippon Shinyaku Co., Ltd. |
Method of manufacturing solid dispersion
|
WO1993007859A1
(en)
|
1991-10-23 |
1993-04-29 |
Warner-Lambert Company |
Novel pharmaceutical pellets and process for their production
|
DE4138513A1
(de)
|
1991-11-23 |
1993-05-27 |
Basf Ag |
Feste pharmazeutische retardform
|
WO1993011749A1
(en)
|
1991-12-18 |
1993-06-24 |
Warner-Lambert Company |
A process for the preparation of a solid dispersion
|
DE4200821A1
(de)
|
1992-01-15 |
1993-07-22 |
Bayer Ag |
Geschmacksmaskierte pharmazeutische mittel
|
DE4201179A1
(de)
*
|
1992-01-17 |
1993-07-22 |
Alfatec Pharma Gmbh |
Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
|
DE69331930T2
(de)
|
1992-02-18 |
2003-01-09 |
Pharmos Corp., New York |
Trockene zusammensetzungen zur herstellung von emulsionen im submikron-bereich
|
US5654003A
(en)
|
1992-03-05 |
1997-08-05 |
Fuisz Technologies Ltd. |
Process and apparatus for making tablets and tablets made therefrom
|
ZA932268B
(en)
|
1992-03-30 |
1993-11-11 |
Alza Corp |
Polymer system containing a partially soluble compound
|
CA2095776C
(en)
|
1992-05-12 |
2007-07-10 |
Richard C. Fuisz |
Rapidly dispersable compositions containing polydextrose
|
IT1256026B
(it)
|
1992-06-12 |
1995-11-20 |
|
Sali del glutatione etilestere
|
DE4220782A1
(de)
*
|
1992-06-25 |
1994-01-05 |
Basf Ag |
Verfahren zur Herstellung von festen pharmazeutischen Retardformen
|
DE4226753A1
(de)
|
1992-08-13 |
1994-02-17 |
Basf Ag |
Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen
|
US5968942A
(en)
|
1992-08-25 |
1999-10-19 |
G. D. Searle & Co. |
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
IS2334B
(is)
|
1992-09-08 |
2008-02-15 |
Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) |
Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
|
US5484926A
(en)
*
|
1993-10-07 |
1996-01-16 |
Agouron Pharmaceuticals, Inc. |
HIV protease inhibitors
|
GB9306887D0
(en)
|
1993-04-01 |
1993-05-26 |
Graham Neil B |
Random block copolymers
|
EP0717988B1
(en)
|
1993-08-20 |
2001-10-17 |
Nippon Shinyaku Company, Limited |
Gastric remaining preparation, swollen molding, and production process
|
US5773025A
(en)
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
IL110752A
(en)
*
|
1993-09-13 |
2000-07-26 |
Abbott Lab |
Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
|
US5559158A
(en)
*
|
1993-10-01 |
1996-09-24 |
Abbott Laboratories |
Pharmaceutical composition
|
WO1995014037A1
(en)
*
|
1993-11-17 |
1995-05-26 |
Ibah, Inc. |
Transparent liquid for encapsulated drug delivery
|
KR100354702B1
(ko)
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
IL111991A
(en)
|
1994-01-28 |
2000-07-26 |
Abbott Lab |
Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
|
AU1806895A
(en)
|
1994-02-23 |
1995-09-11 |
Bm Research A/S |
Controlled release composition
|
DE4413350A1
(de)
|
1994-04-18 |
1995-10-19 |
Basf Ag |
Retard-Matrixpellets und Verfahren zu ihrer Herstellung
|
IL129871A
(en)
|
1994-05-06 |
2003-11-23 |
Pharmacia & Upjohn Inc |
Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
|
DE19509807A1
(de)
*
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
|
US5443178A
(en)
|
1994-06-23 |
1995-08-22 |
Allergan, Inc. |
Tablet dispensing system
|
FR2722984B1
(fr)
|
1994-07-26 |
1996-10-18 |
Effik Lab |
Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
|
AU3533395A
(en)
|
1994-09-30 |
1996-04-26 |
Takeda Chemical Industries Ltd. |
Oral sustained-release preparation
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
DE4446468A1
(de)
|
1994-12-23 |
1996-06-27 |
Basf Ag |
Verfahren zur Herstellung von umhüllten Tabletten
|
DE4446467A1
(de)
|
1994-12-23 |
1996-06-27 |
Basf Ag |
Verfahren zur Herstellung von linsenförmigen Tabletten durch Schmelzkalandrierung
|
DE4446470A1
(de)
|
1994-12-23 |
1996-06-27 |
Basf Ag |
Verfahren zur Herstellung von teilbaren Tabletten
|
US5545628A
(en)
|
1995-01-10 |
1996-08-13 |
Galephar P.R. Inc. |
Pharmaceutical composition containing fenofibrate
|
DE19500977C2
(de)
|
1995-01-14 |
1999-01-07 |
Lohmann Therapie Syst Lts |
Feste Arzneimittelform mit in polymerem Material verteiltem Wirkstoff
|
NZ270439A
(en)
|
1995-02-02 |
1996-04-26 |
Bernard Charles Sherman |
Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer
|
DE19504832A1
(de)
|
1995-02-14 |
1996-08-22 |
Basf Ag |
Feste Wirkstoff-Zubereitungen
|
DE19509805A1
(de)
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
|
DE19509806A1
(de)
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Lagerstabile Arzneiformen
|
KR19980703876A
(ko)
|
1995-04-14 |
1998-12-05 |
스티븐 엘. 허스트 |
분산성이 개선된 분말화된 약학적 조성물
|
SI9500173B
(sl)
*
|
1995-05-19 |
2002-02-28 |
Lek, |
Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
|
US5567823A
(en)
|
1995-06-06 |
1996-10-22 |
Abbott Laboratories |
Process for the preparation of an HIV protease inhibiting compound
|
SE9502244D0
(sv)
|
1995-06-20 |
1995-06-20 |
Bioglan Ab |
A composition and a process for the preparation thereof
|
US6037157A
(en)
*
|
1995-06-29 |
2000-03-14 |
Abbott Laboratories |
Method for improving pharmacokinetics
|
FR2736550B1
(fr)
*
|
1995-07-14 |
1998-07-24 |
Sandoz Sa |
Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
|
TW487582B
(en)
|
1995-08-11 |
2002-05-21 |
Nissan Chemical Ind Ltd |
Method for converting sparingly water-soluble medical substance to amorphous state
|
DE69617245T2
(de)
|
1995-08-17 |
2002-07-25 |
Csir, Pretoria |
Produkte mit gesteuerter freisetzung
|
DE19531277A1
(de)
|
1995-08-25 |
1997-02-27 |
Basf Ag |
Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
|
US6391338B1
(en)
|
1995-09-07 |
2002-05-21 |
Biovail Technologies Ltd. |
System for rendering substantially non-dissoluble bio-affecting agents bio-available
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
DE19536394A1
(de)
*
|
1995-09-29 |
1997-04-03 |
Basf Ag |
Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze
|
DE19536387A1
(de)
|
1995-09-29 |
1997-04-03 |
Basf Ag |
Verfahren zur Herstellung von vitaminhaltigen festen Zubereitungen
|
WO1997013503A1
(en)
|
1995-10-13 |
1997-04-17 |
The Penn State Research Foundation |
Synthesis of drug nanoparticles by spray drying
|
DE19539361A1
(de)
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
|
DE19539574A1
(de)
*
|
1995-10-25 |
1997-04-30 |
Boehringer Mannheim Gmbh |
Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
|
US5914332A
(en)
|
1995-12-13 |
1999-06-22 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
US5858401A
(en)
*
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
DE19602206A1
(de)
|
1996-01-23 |
1997-07-24 |
Basf Ag |
Zubereitungen nichtsteroidaler Analgetika
|
US5958455A
(en)
|
1996-02-09 |
1999-09-28 |
Quadrant Holdings Cambridge Ltd |
Oral solid dosage forms, methods of making same and compositions thereof
|
US5762961A
(en)
|
1996-02-09 |
1998-06-09 |
Quadrant Holdings Cambridge Ltd. |
Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
|
GB2311027B
(en)
|
1996-03-15 |
1999-10-27 |
Johnson & Johnson Medical |
Coated bioabsorbable beads for wound treatment
|
US20030064108A1
(en)
|
1996-04-23 |
2003-04-03 |
Stefan Lukas |
Taste masked pharmaceutical compositions
|
DE19617716A1
(de)
|
1996-05-03 |
1997-11-06 |
Basf Ag |
In wäßriger Lösung redispergierbare Polymerpulver
|
US5834472A
(en)
|
1996-05-24 |
1998-11-10 |
Schering Corporation |
Antifungal composition with enhanced bioavailability
|
US6764690B2
(en)
|
1996-05-29 |
2004-07-20 |
Delsitech Oy |
Dissolvable oxides for biological applications
|
US5935936A
(en)
|
1996-06-03 |
1999-08-10 |
Genzyme Corporation |
Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
|
WO1997046222A1
(en)
|
1996-06-03 |
1997-12-11 |
Merck & Co., Inc. |
Pediatric formulation for hiv protease inhibitors
|
DE19624607A1
(de)
|
1996-06-20 |
1998-01-02 |
Basf Ag |
Verfahren zur Herstellung von Salzen von Säuregruppen tragenden pharmazeutischen Wirkstoffen
|
WO1997049384A1
(en)
|
1996-06-26 |
1997-12-31 |
Board Of Regents, The University Of Texas System |
Hot-melt extrudable pharmaceutical formulation
|
DE19629753A1
(de)
|
1996-07-23 |
1998-01-29 |
Basf Ag |
Verfahren zur Herstellung von festen Arzneiformen
|
DE19635676A1
(de)
|
1996-09-03 |
1998-03-05 |
Basf Ag |
Feste geschäumte Wirkstoffzubereitungen
|
DE19637479A1
(de)
|
1996-09-13 |
1998-03-19 |
Basf Ag |
Verfahren zur Herstellung fester pharmazeutischer Formen
|
HRP970485A2
(en)
|
1996-09-13 |
1998-08-31 |
Joerg Rosenberg |
Process for producing solid pharmaceutical forms
|
US6071539A
(en)
|
1996-09-20 |
2000-06-06 |
Ethypharm, Sa |
Effervescent granules and methods for their preparation
|
US6488961B1
(en)
|
1996-09-20 |
2002-12-03 |
Ethypharm, Inc. |
Effervescent granules and methods for their preparation
|
US6649186B1
(en)
|
1996-09-20 |
2003-11-18 |
Ethypharm |
Effervescent granules and methods for their preparation
|
US5727878A
(en)
*
|
1996-10-17 |
1998-03-17 |
Cdf Corporation |
Liner for a mixing container and an assembly and method for mixing fluid components
|
US8828432B2
(en)
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
US20010006677A1
(en)
|
1996-10-29 |
2001-07-05 |
Mcginity James W. |
Effervescence polymeric film drug delivery system
|
DE59711923D1
(de)
|
1996-11-15 |
2004-10-21 |
Merck Patent Gmbh |
Verfahren zur herstellung von geformten oder ungeformten polyolmassen und hergestelle zusammensetzungen
|
US6232333B1
(en)
|
1996-11-21 |
2001-05-15 |
Abbott Laboratories |
Pharmaceutical composition
|
ZA9710071B
(en)
|
1996-11-21 |
1998-05-25 |
Abbott Lab |
Pharmaceutical composition.
|
TW486370B
(en)
|
1996-12-25 |
2002-05-11 |
Yamanouchi Pharma Co Ltd |
Rapidly disintegrable pharmaceutical composition
|
US6045829A
(en)
|
1997-02-13 |
2000-04-04 |
Elan Pharma International Limited |
Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
|
US6197787B1
(en)
*
|
1997-03-03 |
2001-03-06 |
Sanofi-Synthelabo |
Pharmaceutical formulations containing poorly soluble drug substances
|
DE19709663A1
(de)
|
1997-03-10 |
1998-09-17 |
Basf Ag |
Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen
|
DE19710009A1
(de)
|
1997-03-12 |
1998-09-24 |
Knoll Ag |
Mehrphasige wirkstoffhaltige Zubereitungsformen
|
DE19710213A1
(de)
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Verfahren zur Herstellung von festen Kombinationsarzneiformen
|
US5948426A
(en)
|
1997-05-03 |
1999-09-07 |
Jefferies; Steven R. |
Method and article to induce hematopoietic expansion
|
US6610764B1
(en)
|
1997-05-12 |
2003-08-26 |
Metabolix, Inc. |
Polyhydroxyalkanoate compositions having controlled degradation rates
|
DE19721467A1
(de)
|
1997-05-22 |
1998-11-26 |
Basf Ag |
Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
|
GB9710699D0
(en)
*
|
1997-05-24 |
1997-07-16 |
Danbiosyst Uk |
Gastro-retentive controlled release system
|
JPH1125076A
(ja)
|
1997-06-30 |
1999-01-29 |
Fujitsu Ltd |
文書管理装置および文書管理プログラム記憶媒体
|
US5955475A
(en)
|
1997-06-30 |
1999-09-21 |
Endo Pharmaceuticals Inc. |
Process for manufacturing paroxetine solid dispersions
|
EP0896823B1
(en)
*
|
1997-07-15 |
2002-09-25 |
Development Center For Biotechnology |
Improved stabilization of Misoprostol
|
DE19733505A1
(de)
|
1997-08-01 |
1999-02-04 |
Knoll Ag |
Schnell wirksames Analgeticum
|
DK0901786T3
(da)
|
1997-08-11 |
2007-10-08 |
Pfizer Prod Inc |
Faste farmaceutiske dispersioner med foröget biotilgængelighed
|
HN1998000115A
(es)
|
1997-08-21 |
1999-06-02 |
Warner Lambert Co |
Formas de dosificación farmacéuticas sólidas
|
WO1999013864A2
(en)
|
1997-09-19 |
1999-03-25 |
Shire Laboratories, Inc. |
Solid solution beadlet
|
JP3460538B2
(ja)
|
1997-10-08 |
2003-10-27 |
救急薬品工業株式会社 |
速溶性フィルム製剤
|
US20020164374A1
(en)
*
|
1997-10-29 |
2002-11-07 |
John Jackson |
Polymeric systems for drug delivery and uses thereof
|
US6027747A
(en)
*
|
1997-11-11 |
2000-02-22 |
Terracol; Didier |
Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
|
CA2310847C
(en)
|
1997-11-28 |
2007-03-13 |
Knoll Aktiengesellschaft |
Method for producing solvent-free non-crystalline biologically active substances
|
DE19753298A1
(de)
*
|
1997-12-01 |
1999-06-02 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
US6632455B2
(en)
|
1997-12-22 |
2003-10-14 |
Schering Corporation |
Molecular dispersion composition with enhanced bioavailability
|
JPH11271927A
(ja)
*
|
1998-01-20 |
1999-10-08 |
Mitsubishi Paper Mills Ltd |
画像材料用支持体
|
GB9802088D0
(en)
|
1998-01-30 |
1998-03-25 |
Scherer Ltd R P |
Pharmaceutical products
|
US6787157B1
(en)
|
1998-03-10 |
2004-09-07 |
Abbott Laboratories |
Multiphase active ingredient-containing formulations
|
US6589554B1
(en)
|
1998-03-16 |
2003-07-08 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tablets quickly disintegrating in the oral cavity and process for producing the same
|
DE19812688A1
(de)
|
1998-03-23 |
1999-09-30 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
DE19814730A1
(de)
|
1998-04-02 |
1999-10-07 |
Basf Ag |
Verwendung von N-Vinyllacram oder N-Vinylamin haltigen Copolymeren als Matrix zur Herstellung von festen pharmazeutischen und kosmetischen Darreichungsformen
|
US20040062802A1
(en)
|
1998-04-02 |
2004-04-01 |
Hermelin Victor M. |
Maximizing effectiveness of substances used to improve health and well being
|
DE19814739A1
(de)
|
1998-04-02 |
1999-10-07 |
Basf Ag |
Verwendung von Polyalkylenoxid-haltigen Pfropfpolymerisaten als Solubilisatoren
|
US5945123A
(en)
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
WO1999052491A1
(fr)
|
1998-04-08 |
1999-10-21 |
Kyowa Hakko Kogyo Co., Ltd. |
Comprimes et procede de fabrication correspondant
|
WO1999055774A1
(en)
|
1998-04-24 |
1999-11-04 |
Eastman Chemical Company |
Coprecipitation of cellulose esters with functional additives and compositions thus obtainable
|
JP4027535B2
(ja)
|
1998-05-26 |
2007-12-26 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
脂溶性薬物を含有した粉末
|
AU771960B2
(en)
|
1998-06-05 |
2004-04-08 |
Forbes Medi-Tech Inc. |
Compositions comprising phytosterol and/or phytostanol having enhanced solubility and dispersability
|
DE1003485T1
(de)
|
1998-06-11 |
2000-11-02 |
Em Industries, Inc. |
Mikroosmotisches gesteuertes arzneistoffabgabesysteme
|
KR100336090B1
(ko)
|
1998-06-27 |
2002-05-27 |
윤승원 |
오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
|
US6894171B1
(en)
|
1998-07-20 |
2005-05-17 |
Abbott Laboratories |
Polymorph of a pharmaceutical
|
MY145265A
(en)
*
|
1998-07-20 |
2012-01-13 |
Abbott Lab |
Amorphous ritonavir
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
US20010021372A1
(en)
|
1998-08-18 |
2001-09-13 |
Tore Omtveit |
Apparatus having partially gold-plated surface
|
DE19839276A1
(de)
|
1998-08-28 |
2000-03-02 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
DE19840256A1
(de)
*
|
1998-09-03 |
2000-03-09 |
Basf Ag |
Verfahren zur Herstellung von beschichteten festen Dosierungsformen
|
DE19841244A1
(de)
|
1998-09-09 |
2000-03-16 |
Knoll Ag |
Verfahren und Vorrichtung zum Herstellen von Tabletten
|
DE19842914A1
(de)
|
1998-09-18 |
2000-03-23 |
Basf Ag |
Testsystem zur Charakterisierung der Verträglichkeit von biologisch aktiven Substanzen und Polyvinylpyrrolidon
|
DE19842753A1
(de)
|
1998-09-18 |
2000-03-23 |
Bayer Ag |
Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
|
DE19843904A1
(de)
|
1998-09-24 |
2000-03-30 |
Basf Ag |
Feste Dosierungsform mit polymerem Bindemittel
|
US20040013613A1
(en)
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US6383594B2
(en)
*
|
1998-10-07 |
2002-05-07 |
Johns Manville International, Inc. |
Pre-cut fibrous insulation for custom fitting building cavities of different widths
|
DE19847618A1
(de)
|
1998-10-15 |
2000-04-20 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
US6502135B1
(en)
|
1998-10-30 |
2002-12-31 |
Science Applications International Corporation |
Agile network protocol for secure communications with assured system availability
|
DE19853985A1
(de)
|
1998-11-23 |
2000-05-25 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
DE19855440A1
(de)
|
1998-12-01 |
2000-06-08 |
Basf Ag |
Verfahren zum Herstellen fester Darreichungsformen mittels Schmelzextrusion
|
DE19856147A1
(de)
|
1998-12-04 |
2000-06-08 |
Knoll Ag |
Teilbare feste Dosierungsformen und Verfahren zu ihrer Herstellung
|
DE19856432A1
(de)
*
|
1998-12-08 |
2000-06-15 |
Basf Ag |
Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
|
AT407111B
(de)
|
1998-12-22 |
2000-12-27 |
Gergely Dr & Co |
Zucker- und/oder zuckeralkoholhältiges matrixmaterial und verfahren zu seiner herstellung
|
WO2000040220A1
(en)
|
1999-01-06 |
2000-07-13 |
Korea Research Institute Of Chemical Technology |
Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same
|
DE19901383A1
(de)
|
1999-01-15 |
2000-07-20 |
Knoll Ag |
Verfahren zur Herstellung unterschiedlicher fester Dosierungsformen
|
US6706283B1
(en)
*
|
1999-02-10 |
2004-03-16 |
Pfizer Inc |
Controlled release by extrusion of solid amorphous dispersions of drugs
|
EP1027887B1
(en)
|
1999-02-10 |
2008-08-13 |
Pfizer Products Inc. |
Matrix controlled release device
|
ES2307482T3
(es)
*
|
1999-02-10 |
2008-12-01 |
Pfizer Products Inc. |
Dispersiones farmaceuticas solidas.
|
US6440946B1
(en)
*
|
1999-02-25 |
2002-08-27 |
Takeda Chemical Industries, Ltd. |
Multiple-agents-binding compound, production and use thereof
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
DE19911097A1
(de)
|
1999-03-12 |
2000-09-14 |
Basf Ag |
Verfahren zur Herstellung von festen cyclodextrinhaltigen Dosierungsformen
|
JP2003531099A
(ja)
|
1999-03-24 |
2003-10-21 |
エフ エム シー コーポレーション |
改良された水溶解度をもつ医薬製剤
|
DE19913692A1
(de)
*
|
1999-03-25 |
2000-09-28 |
Basf Ag |
Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
|
DE19913606A1
(de)
|
1999-03-25 |
2000-09-28 |
Basf Ag |
Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
FR2793689B1
(fr)
|
1999-05-19 |
2001-08-24 |
Pf Medicament |
Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
|
US7919119B2
(en)
*
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6465011B2
(en)
|
1999-05-29 |
2002-10-15 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
NL1012300C2
(nl)
|
1999-06-11 |
2000-12-12 |
Rijksuniversiteit |
Stabilisator voor farmaca.
|
FR2795326B1
(fr)
|
1999-06-28 |
2001-08-31 |
Adir |
Composition pharmaceutique solide thermoformable a liberation controlee
|
DE19930454A1
(de)
|
1999-07-02 |
2001-01-04 |
Knoll Ag |
Feste Paroxetin enthaltende Zubereitungen
|
DE19934610A1
(de)
|
1999-07-23 |
2001-01-25 |
Bayer Ag |
Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
|
US6284270B1
(en)
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
DE19943501A1
(de)
|
1999-09-10 |
2001-03-15 |
Basf Ag |
Unterwassergranulation wirkstoffhaltiger Schmelzen
|
SE9903236D0
(sv)
|
1999-09-10 |
1999-09-10 |
Astra Ab |
Method to obtain microparticles
|
WO2001022939A1
(en)
|
1999-09-29 |
2001-04-05 |
Fmc Corporation |
Hydrolyzed cellulose granulations of salts of drugs
|
DE19949897A1
(de)
|
1999-10-15 |
2001-04-19 |
Rainer Rogasch |
Formkörper und Verfahren zu dessen Herstellung
|
US6264981B1
(en)
|
1999-10-27 |
2001-07-24 |
Anesta Corporation |
Oral transmucosal drug dosage using solid solution
|
US6372259B1
(en)
|
1999-11-10 |
2002-04-16 |
University Of Iowa Research Foundation |
Palatable, sustained release drug granules
|
EP1175205B1
(en)
|
1999-11-12 |
2006-06-14 |
Abbott Laboratories |
Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
|
US7364752B1
(en)
|
1999-11-12 |
2008-04-29 |
Abbott Laboratories |
Solid dispersion pharamaceutical formulations
|
DK1227797T3
(da)
|
1999-11-12 |
2005-05-30 |
Abbott Lab |
Farmaceutiske faststofdispersionsformuleringer
|
DE19958007A1
(de)
|
1999-12-02 |
2001-06-07 |
Roehm Gmbh |
Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen
|
DE19960494A1
(de)
*
|
1999-12-15 |
2001-06-21 |
Knoll Ag |
Vorrichtung und Verfahren zum Herstellen von festen wirkstoffhaltigen Formen
|
DE19961334A1
(de)
|
1999-12-17 |
2001-06-21 |
Roehm Gmbh |
Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere
|
JP5159012B2
(ja)
|
1999-12-23 |
2013-03-06 |
メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド |
不良溶解性の薬物に対する改良された医薬組成物
|
DZ3227A1
(fr)
*
|
1999-12-23 |
2001-07-05 |
Pfizer Prod Inc |
Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
|
YU35302A
(sh)
*
|
1999-12-23 |
2005-03-15 |
Pfizer Products Inc. |
Dozirani oblik leka sa inicijalnim hidrogelom
|
DE10000792A1
(de)
|
2000-01-11 |
2001-07-19 |
Bernhard C Lippold |
Formulierungen von Wirkstoffen in Form einer festen Dispersion
|
US7029700B2
(en)
|
2000-01-14 |
2006-04-18 |
Brown University Research Foundation |
Micronized freeze-dried particles
|
JP2001217428A
(ja)
*
|
2000-01-25 |
2001-08-10 |
Samsung Electronics Co Ltd |
低温多結晶シリコン形薄膜トランジスタ−及びその製造方法
|
GB0003782D0
(en)
|
2000-02-17 |
2000-04-05 |
Dumex Ltd As |
Process
|
GB0005016D0
(en)
|
2000-03-01 |
2000-04-26 |
Jumik Technologies Limited |
PVA-Containing compositions
|
US20030104065A1
(en)
|
2000-03-09 |
2003-06-05 |
Arne Brodin |
Method of preparing solid dispersions
|
GT200100039A
(es)
|
2000-03-16 |
2001-12-31 |
Pfizer |
Inhibidor de la glucogeno fosforilasa.
|
DE10013289A1
(de)
|
2000-03-17 |
2001-09-20 |
Knoll Ag |
Torasemid enthaltende pharmazeutische Zubereitungen
|
DE10015479A1
(de)
|
2000-03-29 |
2001-10-11 |
Basf Ag |
Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
|
US6608198B2
(en)
|
2000-03-30 |
2003-08-19 |
Abbott Laboratories |
Crystalline pharmaceutical
|
GB0008785D0
(en)
|
2000-04-10 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
DE10021539C1
(de)
|
2000-05-03 |
2002-02-28 |
Henkel Kgaa |
Vorrichtung zur Sprühtrocknung von lösungsmittelhaltigen Zusammensetzungen
|
US20020001617A1
(en)
*
|
2000-05-26 |
2002-01-03 |
Chang-Hyun Lee |
Rapidly disintegrating tablet and process for the manufacture thereof
|
DE10026698A1
(de)
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
DE10026699A1
(de)
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage
|
DE10029201A1
(de)
|
2000-06-19 |
2001-12-20 |
Basf Ag |
Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
|
WO2002002081A1
(en)
|
2000-07-05 |
2002-01-10 |
Capricorn Pharma, Inc. |
Rapid-melt semi-solid compositions, methods of making same and methods of using same
|
US20100010101A1
(en)
*
|
2000-07-05 |
2010-01-14 |
Capricorn Pharma, Inc. |
Rapid-Melt Compositions and Methods of Making Same
|
IT1318618B1
(it)
|
2000-07-10 |
2003-08-27 |
A C R Applied Coating Res S A |
Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
|
AU2001289653A1
(en)
|
2000-07-14 |
2002-01-30 |
Universiteit Gent |
Composite solid shaped articles for the controlled delivery of biologically active ingredients
|
DE10038571A1
(de)
*
|
2000-08-03 |
2002-02-14 |
Knoll Ag |
Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen
|
US20030099703A1
(en)
|
2000-08-11 |
2003-05-29 |
Shigeru Aoki |
Drug-containing solid dispersion having improved solubility
|
US6372905B1
(en)
*
|
2000-08-31 |
2002-04-16 |
Abbott Laboratories |
Processes and intermediates for preparing retroviral protease inhibitors
|
DE10046541A1
(de)
*
|
2000-09-19 |
2002-03-28 |
Knoll Ag |
Mechanisch stabile darreichungsformen, enthaltend Ubichinone
|
FR2814366A1
(fr)
*
|
2000-09-22 |
2002-03-29 |
Rhodia Chimie Sa |
Procede de granulation de matieres actives par extrusion basse pression pour l'obtention de granules directement compressibles
|
US20040013736A1
(en)
*
|
2000-09-25 |
2004-01-22 |
Tomio Nakano |
Process for producing medicinal solid dispersion
|
JP2004509739A
(ja)
|
2000-09-27 |
2004-04-02 |
ベリオン インコーポレイテッド |
即時水溶解性カプセルおよびその製法
|
US6579521B2
(en)
*
|
2000-10-20 |
2003-06-17 |
Chiron Corporation |
Methods of therapy for HIV infection
|
WO2002035991A2
(en)
|
2000-10-30 |
2002-05-10 |
The Board Of Regents, The University Of Texas System |
Spherical particles produced by a hot-melt extrusion/spheronization process
|
GB0026593D0
(en)
*
|
2000-10-31 |
2000-12-13 |
Quadrant Holdings Cambridge |
Derivatised carbohydrates and their use in solid delivery systems
|
WO2002038126A2
(en)
|
2000-11-08 |
2002-05-16 |
Aeromatic-Fielder Ag |
A process for production of particles for pharmaceutical compositions having increased bioavailability
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
AU2002214466A1
(en)
|
2000-11-09 |
2002-05-21 |
Astrazeneca Ab |
Oral pharmaceutical composition containing a block copolymer
|
US6733781B2
(en)
|
2000-12-06 |
2004-05-11 |
Wyeth |
Fast dissolving tablet
|
GB0029843D0
(en)
|
2000-12-07 |
2001-01-24 |
Univ Belfast |
Drug delivery system
|
US7883721B2
(en)
|
2001-01-30 |
2011-02-08 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
US20050175687A1
(en)
|
2001-01-30 |
2005-08-11 |
Mcallister Stephen M. |
Pharmaceutical formulations
|
US7842308B2
(en)
|
2001-01-30 |
2010-11-30 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
CA2434835A1
(en)
|
2001-02-13 |
2002-08-22 |
Astrazeneca Ab |
Novel modified released formulation
|
GB0104752D0
(en)
|
2001-02-27 |
2001-04-18 |
Astrazeneca Ab |
Pharmaceutical compositions
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
MXPA03010054A
(es)
*
|
2001-05-01 |
2004-04-02 |
Abbott Lab |
Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos.
|
KR100554816B1
(ko)
*
|
2001-05-03 |
2006-02-22 |
에프. 호프만-라 로슈 아게 |
비결정질 넬피나비르 메실레이트의 약학 제형
|
AR033711A1
(es)
|
2001-05-09 |
2004-01-07 |
Novartis Ag |
Composiciones farmaceuticas
|
CA2447693A1
(en)
|
2001-05-31 |
2002-12-05 |
Cima Labs Inc. |
Taste-masking of highly water-soluble drugs
|
DE10127134A1
(de)
|
2001-06-05 |
2002-12-12 |
Roehm Gmbh |
verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
|
US6730319B2
(en)
*
|
2001-06-06 |
2004-05-04 |
Hoffmann-La Roche Inc. |
Pharmaceutical compositions having depressed melting points
|
US20030212102A1
(en)
|
2001-06-12 |
2003-11-13 |
Koretke Todd W |
Novel solid dispersion compositions
|
DE60238193D1
(de)
|
2001-06-22 |
2010-12-16 |
Pfizer Prod Inc |
Pharmazeutische zusammensetzungen, enthaltend adsorbate eines arzneimittels in amorpher form
|
IL158991A0
(en)
*
|
2001-06-22 |
2004-05-12 |
Pfizer Prod Inc |
Pharmaceutical compositions comprising low-solubility and/or acid sensitive drugs and neutralized acidic polymers
|
BR0211028A
(pt)
|
2001-06-22 |
2004-06-15 |
Pfizer Prod Inc |
Solução aquosa, método para formação de associações de fármaco e polìmero, composições farmacêuticas, método para formação de uma composição farmacêutica e produto
|
JP2004534812A
(ja)
|
2001-06-22 |
2004-11-18 |
ファイザー・プロダクツ・インク |
薬物および中性ポリマーの分散物の医薬組成物
|
MXPA03011922A
(es)
|
2001-06-22 |
2004-03-26 |
Pfizer Prod Inc |
Composiciones farmaceuticas que contienen un dispersion solida de un farmaco ligeramente soluble en una matriz y plimero mejorador de solubilidad.
|
EP1269994A3
(en)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising drug and concentration-enhancing polymers
|
ITMI20011337A1
(it)
|
2001-06-26 |
2002-12-26 |
Farmatron Ltd |
Composizioni farmaceutiche orali a rilascio modificato del principio attivo
|
ITMI20011338A1
(it)
*
|
2001-06-26 |
2002-12-26 |
Farmatron Ltd |
Composizioni farmaceutiche orali a rilascio immediato del principio attivo
|
ES2739852T3
(es)
*
|
2001-07-06 |
2020-02-04 |
Veloxis Pharmaceuticals As |
Aglomeración controlada
|
US20030044474A1
(en)
|
2001-08-03 |
2003-03-06 |
Shaklee Corporation |
High molecular weight, lipophilic, orally ingestible bioactive agents in formulations having improved bioavailability
|
FR2828380B1
(fr)
|
2001-08-10 |
2005-07-29 |
Fontarome |
Composition a structure composite contenant des substances aromatiques et/ou des substances non aromatiques volatiles et/ou sensibles aux agents exterieurs, et son procede de fabrication
|
JP4644397B2
(ja)
*
|
2001-09-05 |
2011-03-02 |
信越化学工業株式会社 |
難溶性薬物を含む医薬用固形製剤の製造方法
|
ATE381924T1
(de)
|
2001-09-21 |
2008-01-15 |
Egalet As |
Feste dispersionen mit kontrollierter freisetzung von carvedilol
|
US6982094B2
(en)
|
2001-09-28 |
2006-01-03 |
Mcneil-Ppc, Inc. |
Systems, methods and apparatuses for manufacturing dosage forms
|
CN1596100A
(zh)
|
2001-09-28 |
2005-03-16 |
麦克内尔-Ppc股份有限公司 |
可食用组合物及含可食用外壳的制剂
|
US7122143B2
(en)
|
2001-09-28 |
2006-10-17 |
Mcneil-Ppc, Inc. |
Methods for manufacturing dosage forms
|
DE10151290A1
(de)
|
2001-10-22 |
2003-04-30 |
Roehm Gmbh |
Verfahren zur Herstellung von wirkstoffhaltigen Pellets
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
JP2005509001A
(ja)
|
2001-10-29 |
2005-04-07 |
セリクス, インコーポレイテッド |
投薬形態の三次元懸濁液プリンティング
|
US7491407B2
(en)
*
|
2001-10-31 |
2009-02-17 |
North Carolina State University |
Fiber-based nano drug delivery systems (NDDS)
|
JP2003146869A
(ja)
|
2001-11-14 |
2003-05-21 |
Scg:Kk |
口腔内崩壊型固形製剤及びその製造方法
|
US6524606B1
(en)
|
2001-11-16 |
2003-02-25 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters containing amine groups
|
US20030129250A1
(en)
|
2001-11-20 |
2003-07-10 |
Advanced Inhalation Research Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
EP1509204A4
(en)
|
2001-11-29 |
2005-07-13 |
Rettenmaier & Soehne Gmbh & Co |
AGGLOMERATED PARTICLES WITH AN ACTIVE SUBSTANCE PREPARED WITH MELTED MICROCRYSTALLINE CELLULOSE
|
US20030206978A1
(en)
|
2001-11-29 |
2003-11-06 |
Bob Sherwood |
Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
|
US7179488B2
(en)
*
|
2001-11-29 |
2007-02-20 |
Bob Sherwood |
Process for co-spray drying liquid herbal extracts with dry silicified MCC
|
CA2469718A1
(en)
|
2001-12-10 |
2003-06-19 |
Spherics, Inc. |
Methods and products useful in the formation and isolation of microparticles
|
WO2003057197A1
(en)
|
2002-01-03 |
2003-07-17 |
Smithkline Beecham Corporation |
Novel pharmaceutical dosage forms and method for producing same
|
KR100758045B1
(ko)
|
2002-02-01 |
2007-09-11 |
화이자 프로덕츠 인크. |
압력 노즐을 이용하여 균질한 분무 건조된 비결정질 고체약물 분산제를 제조하는 방법
|
JP2005523262A
(ja)
*
|
2002-02-01 |
2005-08-04 |
ファイザー・プロダクツ・インク |
薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
|
JP4865989B2
(ja)
|
2002-02-01 |
2012-02-01 |
ベンド・リサーチ・インコーポレーテッド |
改良された噴霧乾燥装置を使用する均質な噴霧乾燥された固体の非晶質薬物分散物を製造する方法
|
JP2005517690A
(ja)
|
2002-02-01 |
2005-06-16 |
ファイザー・プロダクツ・インク |
固体薬物分散物を含有する即時放出剤形
|
AR038681A1
(es)
*
|
2002-02-14 |
2005-01-26 |
Solvay Pharm Bv |
Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
|
DE10208344A1
(de)
|
2002-02-27 |
2003-09-04 |
Roehm Gmbh |
Schmelzextrusion von Wirkstoffsalzen
|
GB0205253D0
(en)
*
|
2002-03-06 |
2002-04-17 |
Univ Gent |
Immediate release pharmaceutical granule compositions and a continuous process for making them
|
ATE422156T1
(de)
|
2002-03-07 |
2009-02-15 |
Eurand Pharmaceuticals Ltd |
Verfahren zum laden und thermodynamischen aktivieren von arzneimitteln auf polymeren mit superkritischen flüssigkeiten
|
ATE374598T1
(de)
|
2002-03-15 |
2007-10-15 |
Alrise Biosystems Gmbh |
Mikropartikel und verfahren zur deren herstellung
|
DE10213242A1
(de)
|
2002-03-25 |
2003-10-16 |
Abbott Gmbh & Co Kg |
Testsystem zur Evaluierung der Kompatibilität biologisch aktiver Substanzen mit Copolymeren
|
DE10213977A1
(de)
|
2002-03-28 |
2003-10-16 |
Krauss Maffei Kunststofftech |
Verfahren zum Herstellen von Wirkstoffe enthaltenden Formkörpern
|
KR20040098050A
(ko)
|
2002-04-05 |
2004-11-18 |
유로-셀띠끄 소시에떼 아노님 |
옥시코돈 및 날록손을 포함하는 약제학적 제제
|
US20050163853A1
(en)
|
2002-04-19 |
2005-07-28 |
Lajos Szente |
Novel biomaterials their preparation and use
|
US20030203027A1
(en)
|
2002-04-26 |
2003-10-30 |
Ethicon, Inc. |
Coating technique for deposition of drug substance on a substrate
|
US7205413B2
(en)
*
|
2002-05-03 |
2007-04-17 |
Transform Pharmaceuticals, Inc. |
Solvates and polymorphs of ritonavir and methods of making and using the same
|
JP2005532313A
(ja)
*
|
2002-05-07 |
2005-10-27 |
コントロール・デリバリー・システムズ・インコーポレイテッド |
薬物送達装置の形成方法
|
GB0214013D0
(en)
|
2002-06-18 |
2002-07-31 |
Euro Celtique Sa |
Pharmaceutical product
|
MXPA05000232A
(es)
*
|
2002-06-21 |
2005-06-17 |
Transform Pharmaceuticals Inc |
Composiciones farmaceuticas con disolucion mejorada.
|
AR039744A1
(es)
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
CN100515388C
(zh)
*
|
2002-06-26 |
2009-07-22 |
金拓 |
难溶药物快速溶出固体剂型
|
US7155459B2
(en)
*
|
2002-06-28 |
2006-12-26 |
Miccrosoft Corporation |
Time-bound database tuning
|
JP2005538973A
(ja)
|
2002-07-04 |
2005-12-22 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
異なる2種類のポリマーマトリックスを含んで成る固体分散体
|
US7985422B2
(en)
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
TW200410714A
(en)
*
|
2002-08-07 |
2004-07-01 |
Smithkline Beecham Corp |
Electrospun amorphous pharmaceutical compositions
|
CA2496441C
(en)
|
2002-08-12 |
2010-03-16 |
Pfizer Products Inc. |
Pharmaceutical compositions of semi-ordered drugs and polymers
|
DE60316579T2
(de)
|
2002-08-13 |
2008-07-03 |
Medtronic, Inc., Minneapolis |
System zur abgabe von wirkstoffen mit einem hydrophoben cellulose-derivat
|
AU2003258209A1
(en)
|
2002-08-13 |
2004-02-25 |
Medtronic, Inc. |
Active agent delivery systems, medical devices, and methods
|
ATE487470T1
(de)
*
|
2002-09-11 |
2010-11-15 |
Elan Pharma Int Ltd |
Gel-stabilisierte wirkstoff-zusammensetzungen in nanoteilchengrösse
|
US20040062778A1
(en)
|
2002-09-26 |
2004-04-01 |
Adi Shefer |
Surface dissolution and/or bulk erosion controlled release compositions and devices
|
DE10247037A1
(de)
|
2002-10-09 |
2004-04-22 |
Abbott Gmbh & Co. Kg |
Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
|
WO2004098570A1
(en)
|
2002-10-30 |
2004-11-18 |
Spherics, Inc. |
Nanoparticulate bioactive agents
|
FR2846557B1
(fr)
*
|
2002-10-30 |
2007-06-08 |
Statice Sante |
Structure implantable pour la liberation prolongee et controlee d'un principe actif
|
DE10250711A1
(de)
|
2002-10-31 |
2004-05-19 |
Degussa Ag |
Pharmazeutische und kosmetische Zubereitungen
|
AU2002350719A1
(en)
|
2002-11-29 |
2004-06-23 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
|
US7670627B2
(en)
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
WO2004054568A1
(en)
|
2002-12-17 |
2004-07-01 |
Abbott Gmbh & Co. Kg |
Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
|
US6872799B2
(en)
|
2002-12-18 |
2005-03-29 |
Ethicon, Inc. |
Functionalized polymers for medical applications
|
US20040121003A1
(en)
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
MXPA05006802A
(es)
|
2002-12-19 |
2005-09-08 |
Pharmacia Corp |
Formulacion no higroscopica que comprende un farmaco higroscopico.
|
ITMI20022748A1
(it)
|
2002-12-23 |
2004-06-24 |
Eurand Int |
Dispersioni solide stabilizzate di farmaco in un carrier organico e procedimento per la loro preparazione.
|
AU2003205543A1
(en)
|
2003-01-14 |
2004-08-10 |
Lifecycle Pharma A/S |
Dry dispersions
|
DE10304403A1
(de)
*
|
2003-01-28 |
2004-08-05 |
Röhm GmbH & Co. KG |
Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung
|
US20040258752A1
(en)
|
2003-01-31 |
2004-12-23 |
Paruthi Manoj Kumar |
Taste masking pharmaceutical composition and process for its preparation
|
CA2509958A1
(en)
|
2003-02-03 |
2004-08-19 |
Novartis Ag |
Pharmaceutical formulation
|
US20040156894A1
(en)
|
2003-02-07 |
2004-08-12 |
Grother Leon Paul |
Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
|
US6931888B2
(en)
|
2003-02-07 |
2005-08-23 |
Ferro Corporation |
Lyophilization method and apparatus for producing particles
|
US20060286169A1
(en)
|
2003-02-13 |
2006-12-21 |
Phares Pharmaceutical Research N.V. |
Lipophilic compositions
|
GB0304726D0
(en)
*
|
2003-03-01 |
2003-04-02 |
Ardana Bioscience Ltd |
New Process
|
GB0305941D0
(en)
|
2003-03-14 |
2003-04-23 |
Camurus Ab |
Composition
|
US20040185170A1
(en)
|
2003-03-21 |
2004-09-23 |
Shubha Chungi |
Method for coating drug-containing particles and formulations and dosage units formed therefrom
|
US8298581B2
(en)
*
|
2003-03-26 |
2012-10-30 |
Egalet A/S |
Matrix compositions for controlled delivery of drug substances
|
US20040208928A1
(en)
|
2003-04-15 |
2004-10-21 |
Animal Technology Institute Taiwan |
Method for preparing an orally administrable formulation for controlled release
|
CA2523218A1
(en)
*
|
2003-04-22 |
2004-11-04 |
Dr. Reddy's Laboratories Limited |
Oral pharmaceutical formulations of acid-labile active ingredients and process for making same
|
GB0310300D0
(en)
|
2003-05-06 |
2003-06-11 |
Univ Belfast |
Nanocomposite drug delivery composition
|
EP1624859A4
(en)
|
2003-05-06 |
2010-06-23 |
Bpsi Holdings Inc |
METHOD FOR PRODUCING THERMOFORMED COMPOSITIONS WITH ACRYLIC POLYMER BINDERS, PHARMACEUTICAL DOSAGE FORMS, AND METHOD FOR THE PRODUCTION THEREOF
|
JP2004339162A
(ja)
|
2003-05-16 |
2004-12-02 |
Shin Etsu Chem Co Ltd |
難溶性薬物を含む医薬用固形製剤とその製造方法
|
EP1479381A1
(en)
|
2003-05-19 |
2004-11-24 |
Euro-Celtique S.A. |
Pharmaceutical dosage form comprising a solid solution
|
JP2007500234A
(ja)
*
|
2003-05-28 |
2007-01-11 |
ネクター セラピューティクス |
水に不溶な活性剤を含む医薬的成形
|
US20040247624A1
(en)
|
2003-06-05 |
2004-12-09 |
Unger Evan Charles |
Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
DE10325989A1
(de)
|
2003-06-07 |
2005-01-05 |
Glatt Gmbh |
Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
|
EP1638533A1
(en)
|
2003-06-18 |
2006-03-29 |
John Michael Newton |
Controlled release devices with lumens
|
US20040265378A1
(en)
|
2003-06-25 |
2004-12-30 |
Yingxu Peng |
Method and compositions for producing granules containing high concentrations of biologically active substances
|
AU2004255436B2
(en)
|
2003-07-11 |
2006-11-30 |
F. Hoffmann-La Roche Ag |
Saquinavir mesylate oral dosage form
|
DE10332160A1
(de)
|
2003-07-15 |
2005-02-03 |
Röhm GmbH & Co. KG |
Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
|
TW200526274A
(en)
|
2003-07-21 |
2005-08-16 |
Smithkline Beecham Plc |
Pharmaceutical formulations
|
BR0302523A
(pt)
|
2003-07-23 |
2005-04-05 |
Cristalia Prod Quimicos Farm |
Composição farmacêutica estável para administração de inibidores da hiv protease e processo de obtenção de composição farmacêutica concentrada para a administração de inibidores da hiv protease
|
US7785512B1
(en)
|
2003-07-31 |
2010-08-31 |
Advanced Cardiovascular Systems, Inc. |
Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices
|
US7645474B1
(en)
*
|
2003-07-31 |
2010-01-12 |
Advanced Cardiovascular Systems, Inc. |
Method and system of purifying polymers for use with implantable medical devices
|
BRPI0413277A
(pt)
*
|
2003-08-04 |
2006-10-10 |
Pfizer Prod Inc |
composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas
|
JP5180474B2
(ja)
|
2003-08-04 |
2013-04-10 |
カムルス エービー |
両親媒性粒子の特性を改良する方法
|
CL2004001884A1
(es)
*
|
2003-08-04 |
2005-06-03 |
Pfizer Prod Inc |
Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
|
EP1651275A1
(en)
*
|
2003-08-05 |
2006-05-03 |
Fuji Photo Film B.V. |
Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions
|
DE10339197A1
(de)
|
2003-08-22 |
2005-03-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
US8377952B2
(en)
|
2003-08-28 |
2013-02-19 |
Abbott Laboratories |
Solid pharmaceutical dosage formulation
|
US20050048112A1
(en)
|
2003-08-28 |
2005-03-03 |
Jorg Breitenbach |
Solid pharmaceutical dosage form
|
WO2005032525A1
(en)
|
2003-10-03 |
2005-04-14 |
Lifecycle Pharma A/S |
A method for preparing modified release pharmaceutical compositions
|
JP2007509044A
(ja)
|
2003-10-08 |
2007-04-12 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
シクロアルキルピラニル基を含むatp結合カセットトランスポーターのモジュレータ
|
ES2688193T3
(es)
|
2003-10-15 |
2018-10-31 |
Fuji Chemical Industry Co., Ltd. |
Comprimido de disgregación rápida en la cavidad oral
|
US8349361B2
(en)
|
2003-10-15 |
2013-01-08 |
Fuji Chemical Industry Co., Ltd. |
Composition for rapid disintegrating tablet in oral cavity
|
PL1677827T3
(pl)
*
|
2003-10-27 |
2009-06-30 |
Vertex Pharma |
Połączenia do leczenia HCV
|
US7413690B1
(en)
|
2003-10-29 |
2008-08-19 |
The University Of Mississippi |
Process and apparatus for producing spherical pellets using molten solid matrices
|
WO2005055986A1
(en)
|
2003-12-15 |
2005-06-23 |
Council Of Scientific & Industrial Research |
Taste masked pharmaceutical composition comprising ph sensitive polymer
|
CA2568378C
(en)
|
2004-05-28 |
2013-03-19 |
Abbott Gmbh & Co. Kg |
Formulation obtained from a powder mixture comprising an inorganic pigment
|
US20050281876A1
(en)
|
2004-06-18 |
2005-12-22 |
Shun-Por Li |
Solid dosage form for acid-labile active ingredient
|
DE102004040104A1
(de)
|
2004-08-18 |
2006-02-23 |
Basf Ag |
Verwendung von amphiphilen Copolymerisaten als Solubilisatoren
|
GB0501835D0
(en)
|
2005-01-28 |
2005-03-09 |
Unilever Plc |
Improvements relating to spray dried compositions
|
US20090104269A1
(en)
|
2005-02-11 |
2009-04-23 |
Brian Graham |
Nanoformulations
|
BRPI0606187A2
(pt)
|
2005-02-25 |
2009-06-09 |
Hoffmann La Roche |
comprimidos com capacidade de dispersão da substáncia do fármaco melhorada
|
WO2006128253A1
(en)
|
2005-06-03 |
2006-12-07 |
Horizon Science Pty Ltd |
Delivery systems
|
WO2007002041A2
(en)
|
2005-06-21 |
2007-01-04 |
Foster Corporation |
Drug-filled polymer films
|
WO2007012478A2
(en)
|
2005-07-26 |
2007-02-01 |
Glaxo Group Limited |
Encapsulation of lipid-based formulations in enteric polymers
|
PT1912626T
(pt)
|
2005-08-08 |
2016-07-20 |
Abbvie Deutschland |
Formas farmacêuticas com biodisponibilidade melhorada
|
US20100137455A1
(en)
|
2005-08-11 |
2010-06-03 |
Basf Se |
N-vinylcaprolactam-based copolymers and the use thereof as solubilizers
|
RU2385712C2
(ru)
|
2005-08-24 |
2010-04-10 |
Рубикон Рисёч Пвт Лтд. |
Рецептура с контролируемым высвобождением
|
US20070077305A1
(en)
|
2005-10-03 |
2007-04-05 |
Le Tien C |
Biocompatible polymeric matrix and preparation thereof
|
WO2007050631A2
(en)
|
2005-10-25 |
2007-05-03 |
Cima Labs Inc. |
Dosage form with coated active
|
ITMI20052461A1
(it)
*
|
2005-12-22 |
2007-06-23 |
Univ Degli Studi Milano |
Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
|
WO2007091856A1
(en)
|
2006-02-10 |
2007-08-16 |
Lg Household & Health Care Ltd. |
In-situ melting and gelling tablet composition for oral care
|
MX2008012225A
(es)
|
2006-03-23 |
2008-12-03 |
Schering Corp |
Combinaciones de inhibidores de proteasa de virus de hepatitis c e inhibidores de isoenzima 3a4 del citocromo p450, y metodos de tratamiento relacionados con las mismas.
|
US7771632B2
(en)
|
2006-05-15 |
2010-08-10 |
American Leistritz Extruder Corp. |
Continuous melt spheronization apparatus and process for the production of pharmaceutical pellets
|
JP2009540032A
(ja)
|
2006-06-07 |
2009-11-19 |
ビーエーエスエフ ソシエタス・ヨーロピア |
酢酸ビニル−スルホナート共重合体の、水への溶解度が低い化合物のための可溶化剤としての使用
|
US8343548B2
(en)
*
|
2006-08-08 |
2013-01-01 |
Shin-Etsu Chemical Co., Ltd. |
Solid dosage form comprising solid dispersion
|
US7923026B2
(en)
|
2006-10-20 |
2011-04-12 |
Solvay Pharmaceuticals B.V. |
Embedded micellar nanoparticles
|
EP2112925A4
(en)
|
2006-11-15 |
2013-01-09 |
Abbott Lab |
SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
|
WO2008065502A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
|
DE102007009242A1
(de)
|
2007-02-22 |
2008-09-18 |
Evonik Röhm Gmbh |
Pellets mit magensaftresistenter Wirkstoff-Matix
|
US20100204425A1
(en)
|
2007-07-26 |
2010-08-12 |
Basf Se |
Process for preparing copolymers obtained by graft polymerization in solution and based on polyethers in solid form
|
EP2022805A3
(en)
*
|
2007-08-03 |
2009-02-25 |
Basf Se |
Copolymers based on N-vinyllactams and olefins as their use as solubilizers for slightly water-soluble compounds
|
AU2008311350B2
(en)
|
2007-10-11 |
2014-04-03 |
Philip Morris Products S.A. |
Smokeless tobacco product
|
JP5437232B2
(ja)
*
|
2008-03-11 |
2014-03-12 |
あすか製薬株式会社 |
固体分散体とその医薬組成物、並びにそれらの製造方法
|
AR071375A1
(es)
|
2008-04-22 |
2010-06-16 |
Solvay Pharm Gmbh |
Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
|
WO2010017053A1
(en)
|
2008-08-06 |
2010-02-11 |
Isp Investments, Inc. |
Solid excipient compositions
|
GB0815852D0
(en)
|
2008-09-01 |
2008-10-08 |
Unilever Plc |
Improvements relating to pharmaceutical compositions
|
WO2010028489A1
(en)
*
|
2008-09-15 |
2010-03-18 |
Labopharm Inc. |
Starch-based microparticles for the release of agents disposed therein
|
EP2349336B1
(en)
|
2008-10-28 |
2017-11-22 |
Agency For Science, Technology And Research |
Mesoporous material excipients for poorly aqueous soluble ingredients
|
US8715715B2
(en)
|
2008-11-03 |
2014-05-06 |
Nal Pharmaceuticals Ltd. |
Dosage form for insertion into the mouth
|
WO2010078429A1
(en)
|
2008-12-30 |
2010-07-08 |
Impax Laboratories, Inc. |
Pharmaceutical dosage forms and methods of manufacturing same
|
CN101444494B
(zh)
|
2008-12-31 |
2011-03-30 |
江苏大学 |
难溶性药物高效长效缓释制剂及其制法
|
US9005660B2
(en)
|
2009-02-06 |
2015-04-14 |
Egalet Ltd. |
Immediate release composition resistant to abuse by intake of alcohol
|
EP2311435A1
(en)
|
2009-10-07 |
2011-04-20 |
LEK Pharmaceuticals d.d. |
Pharmaceutical composition comprising poorly soluble active ingredient and hyperbranched polymer
|
WO2011090724A2
(en)
|
2009-12-29 |
2011-07-28 |
Impax Laboratories, Inc. |
Gastroretentive solid oral dosage forms with lipid-based low-density excipient
|
CN102821754B
(zh)
|
2010-03-26 |
2014-06-18 |
陶氏环球技术有限责任公司 |
多层熔融挤出膜
|
US20110288181A1
(en)
|
2010-05-21 |
2011-11-24 |
Basf Se |
Preparations of biologically active substances with enlarged surface based on amphiphilic copolymers
|
JP5792807B2
(ja)
|
2010-06-14 |
2015-10-14 |
ダウ グローバル テクノロジーズ エルエルシー |
アセテートおよびサクシネートの置換が向上されたヒドロキシプロピルメチルセルロースアセテートサクシネート
|